Literature DB >> 16951993

Kinetics and mechanism for the reaction of cysteine with hydrogen peroxide in amorphous polyvinylpyrrolidone lyophiles.

Dayong Luo1, Bradley D Anderson.   

Abstract

PURPOSE: Peroxide impurities play a critical role in drug oxidation. In metal-free aqueous solutions, hydrogen peroxide (H(2)O(2)) induced thiol oxidation involves a bimolecular nucleophilic reaction to form a reactive sulfenic acid intermediate (RSOH), which reacts with a second thiol to form a disulfide (RSSR). This study examines the reaction of cysteine (CSH) and H(2)O(2) in amorphous polyvinylpyrrolidone (PVP) lyophiles to explore the possible relevance of the solution mechanism to reactivity in an amorphous glass.
MATERIALS AND METHODS: Amorphous PVP lyophiles containing CSH and H(2)O(2) at varying initial 'pH' and reactant concentrations were prepared by methods designed to minimize reaction during lyophilization. Kinetic studies were conducted anaerobically at 25 degrees C and reactants and products were monitored by HPLC. Products were characterized and the kinetic data were fit to models adapted from the solution mechanism.
RESULTS: Key differences in the reactions in aqueous solution and amorphous PVP are: (1) while only cystine (CSSC) forms in solution, three degradants-cysteine sulfinic acid (CSO(2)H), cysteine sulfonic acid (CSO(3)H) and cystine (CSSC)--form in amorphous PVP; (2) simple bimolecular kinetics govern the solution reaction while initial rates in amorphous PVP suggested more complex kinetics (i.e., non-unity values for reaction order); and (3) heterogeneous (i.e., biphasic) reaction dynamics are evident in amorphous PVP. The differences in product formation and apparent reaction orders in the solid-state could be rationalized by partitioning of the same reactive intermediate to multiple products in the solid-state due to the restricted mobility of CSH. Beyond the initial rate region, the kinetics in amorphous PVP could be described by the Kohlrausch-Williams-Watts (KWW) stretched-exponential equation or by assuming two populations of reactant molecules having different reactivities.
CONCLUSIONS: When reactive intermediates are involved, differences in degradant profiles and other characteristics (e.g., rate constants, apparent reaction order) in the amorphous-state may simply reflect altered rates for individual reaction steps due to glass-induced changes in relative reactant mobilities rather than a change in overall mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951993     DOI: 10.1007/s11095-006-9052-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

1.  Spatially heterogeneous dynamics in supercooled liquids.

Authors:  M D Ediger
Journal:  Annu Rev Phys Chem       Date:  2000       Impact factor: 12.703

2.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

3.  Spatially correlated dynamics in a simulated glass-forming polymer melt: analysis of clustering phenomena.

Authors:  Y Gebremichael; T B Schrøder; F W Starr; S C Glotzer
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2001-10-17

4.  Importance of glass transition temperature in accelerated stability testing of amorphous solids: case study using a lyophilized aspirin formulation.

Authors:  S P Duddu; K Weller
Journal:  J Pharm Sci       Date:  1996-03       Impact factor: 3.534

Review 5.  How does residual water affect the solid-state degradation of drugs in the amorphous state?

Authors:  E Y Shalaev; G Zografi
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

6.  Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions.

Authors:  R G Strickley; B D Anderson
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

7.  Liquid chromatographic determination of residual hydrogen peroxide in pharmaceutical excipients using platinum and wired enzyme electrodes.

Authors:  Tiehua Huang; Michelle E Garceau; Ping Gao
Journal:  J Pharm Biomed Anal       Date:  2003-04-10       Impact factor: 3.935

8.  Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.

Authors:  Anshuman A Ambike; K R Mahadik; Anant Paradkar
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

9.  A molecular dynamics simulation of reactant mobility in an amorphous formulation of a peptide in poly(vinylpyrrolidone).

Authors:  Tian-Xiang Xiang; Bradley D Anderson
Journal:  J Pharm Sci       Date:  2004-04       Impact factor: 3.534

10.  Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Authors:  B C Hancock; S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.